Oppenheimer Maintains Outperform on PACS Group, Raises Price Target to $57
Oppenheimer analyst Michael Wiederhorn maintains PACS Group (NYSE:PACS) with a Outperform and raises the price target from $48 to $57.
Read original at benzingaStocks · News reference
PACS Group Raises FY2026 Sales Guidance from $5.650B-$5.750B to $5.750B-$5.850B vs $5.747B Est
PACS Group (NYSE:PACS) raises FY2026 sales outlook from $5.650 billion-$5.750 billion to $5.750 billion-$5.850 billion vs $5.747 billion estimate.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 4, 2026, 8:11 PM
- Checked
- Aug 4, 2026, 8:11 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
UBS Maintains Buy on PACS Group, Raises Price Target to $60
UBS analyst A.J. Rice maintains PACS Group (NYSE:PACS) with a Buy and raises the price target from $57 to $60.
Read original at benzingaRBC Capital Maintains Outperform on PACS Group, Raises Price Target to $57
RBC Capital analyst Ben Hendrix maintains PACS Group (NYSE:PACS) with a Outperform and raises the price target from $52 to $57.
Read original at benzingaTruist Securities Maintains Buy on PACS Group, Raises Price Target to $62
Truist Securities analyst David Macdonald maintains PACS Group (NYSE:PACS) with a Buy and raises the price target from $52 to $62.
Read original at benzinga